DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Carboplatin
Carboplatin
The Temperature-Dependent Effectiveness of Platinum-Based
Arsenic Trioxide Is Highly Cytotoxic to Small Cell Lung Carcinoma Cells
Review
CARBOPLATIN- Carboplatin Injection Accord Healthcare, Inc
BC Cancer Protocol Summary for Neoadjuvant Or Adjuvant Therapy for Breast Cancer Using Docetaxel, Carboplatin, and Trastuzumab
Chemotherapy Protocol LUNG CANCER – SMALL CELL (SCLC) CARBOPLATIN (AUC6)-ETOPOSIDE (Intravenous / Oral) Regimen SCLC – Carbo
Stability of Carboplatin and Oxaliplatin in Their Infusion Solutions Is Due to Self-Association
Carboplatin /Etoposide (Oral & IV Regimens)
Carboplatin & Pegylated Liposomal Doxorubicin (Caelyx )
Combination Chemotherapy with Estramustine Phosphate, Ifosfamide and Cisplatin for Hormone-Refractory Prostate Cancer
New Strategies Against Prostate Cancer – Pt(II)-Based Chemotherapy
Carboplatin(AUC2)-Paclitaxel RT
Lung Pathway Group – Docetaxel & Carboplatin in Non- Small Cell Lung Cancer (NSCLC)
Drug Discovery, Volume 2, Number 6, December 2012 FDA APPROVED DRUGS 396 5 – DRUG DISCOVERY EISSN 2278 0X 54 – ISSN 2278 FDA Approved Drugs - October 2012
Comparative Study of the Mode of Action of Clinically Approved Platinum-Based Chemotherapeutics
Carboplatin & Liposomal Doxorubicin CARBO-CAELYX Gynaecological Cancer Protocol
BC Cancer Protocol Summary for Treatment of Epithelial Ovarian Cancer Relapsing After Primary Treatment Using Doxorubicin Pegylated Liposomal and Carboplatin
BC Cancer Protocol Summary for Carboplatin and Etoposide in the Treatment of Recurrent Ependymoma and Oligodendroglioma
Top View
Evaluation of Carboplatin Pharmacokinetics in the Absence and Presence of Paclitaxel’
Chapter 12: Pharmacokinetics of Chemotherapeutic Agents in Kidney Disease
Cyclophosphamide and Carboplatin and Selective Consolidation in Advanced Seminoma
CARBOPLATIN & ETOPOSIDE (CE) for SCLC
Your Intravenous (IV) Carboplatin and Paclitaxel Chemotherapy Schedule
Small Cell Lung Cancer Treatment Regimens
HOPA News Volume 10, Issue 1
Targeting the Human 80S Ribosome in Cancer: from Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies
Regimen Reference Order Pegylated Liposomal Doxorubicin + Carboplatin
Comparing Paclitaxel–Carboplatin with Paclitaxel–Cisplatin As the Front-Line Chemotherapy for Patients with FIGO IIIC Serous-Type Tubo-Ovarian Cancer
Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug Administration
Comparison of the Efficacy of Carboplatin, Oxaliplatin and Cisplatin, With
Computationally Predicting Clinical Drug Combination Efficacy With
Arsenoplatins Vs. Combination of Platinum Drugs and Arsenic Trioxide
Pembrolizumab + Paclitaxel + Carboplatin
Carboplatin (AUC5)-Liposomal Doxorubicin (Caelx) Ver 1
Ovarian Cancer Treatment Regimens
BC Cancer Protocol Summary for Treatment of Advanced Squamous Cell Carcinoma of the Head and Neck Cancer Using Fluorouracil and Platinum
GOOVDDCAT Protocol
HEAD and NECK CANCER TREATMENT REGIMENS (Part 1 of 5)
Regimens of Intraperitoneal Chemotherapy for Peritoneal
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)
Regimen Reference Order – GENU – Carboplatin + Etoposide
Carboplatin Injection Are Stable to the Date Indicated on the Package When Stored at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]
Open Full Page
Outcome of Combination Chemotherapy with Docetaxel
Cancer Drug Costs for a Month of Treatment at Initial Food and Drug
Standard Oncology Criteria Policy Number: Pending
Download Master-Thesis
Platinum Derivatives Effects on Anticancer Immune Response
Principles of Antineoplastic Therapy
Year of FDA Monthly Cost Approval
Carboplatin and Fluorouracil
DBL™ Carboplatin Injection, Solution for Injection
Umicore Apis
Docetaxel-Carboplatin As First Line Chemotherapy for Epithelial Ovarian Cancer
Carboplatin (Paraplatin®) Pronounced: “KAR-Boe-Pla-Tin”
Esophageal/Gastric
Regimen Reference Order – GYNE – Docetaxel + Carboplatin
(Mitomycin C / Vinblastine / Carboplatin) in Advanced Breast Cancer
PARAPLATIN Label
TECENTRIQ® + Carboplatin/Etoposide Is NOW FDA APPROVED for the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)
High-Dose Chemotherapy with Carboplatin, Cyclophosphamide and Etoposide and Autologous Transplantation for Multiple Myeloma Relapsing After a Previous Transplant
Docetaxel, Carboplatin, Trastuzumab (Herceptin ®) and Pertuzumab